Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

38Citations
Citations of this article
89Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In prostate cancer (PCa), the use of new radiopharmaceuticals has improved the accuracy of diagnosis and staging, refined surveillance strategies, and introduced specific and personalized radioreceptor therapies. Nuclear medicine, therefore, holds great promise for improving the quality of life of PCa patients, through managing and processing a vast amount of molecular imaging data and beyond, using a multi-omics approach and improving patients’ risk-stratification for tailored medicine. Artificial intelligence (AI) and radiomics may allow clinicians to improve the overall efficiency and accuracy of using these “big data” in both the diagnostic and theragnostic field: from technical aspects (such as semi-automatization of tumor segmentation, image reconstruction, and interpretation) to clinical outcomes, improving a deeper understanding of the molecular environment of PCa, refining personalized treatment strategies, and increasing the ability to predict the outcome. This systematic review aims to describe the current literature on AI and radiomics applied to molecular imaging of prostate cancer.

References Powered by Scopus

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

76716Citations
N/AReaders
Get full text

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

8862Citations
N/AReaders
Get full text

Radiomics: The bridge between medical imaging and personalized medicine

3858Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Artificial intelligence-aided optical imaging for cancer theranostics

22Citations
N/AReaders
Get full text

Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects

21Citations
N/AReaders
Get full text

Application of Machine Learning for Differentiating Bone Malignancy on Imaging: A Systematic Review

14Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Liberini, V., Laudicella, R., Balma, M., Nicolotti, D. G., Buschiazzo, A., Grimaldi, S., … Deandreis, D. (2022, December 1). Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics. European Radiology Experimental. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1186/s41747-022-00282-0

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

52%

Researcher 9

33%

Professor / Associate Prof. 3

11%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

59%

Computer Science 3

14%

Engineering 3

14%

Biochemistry, Genetics and Molecular Bi... 3

14%

Save time finding and organizing research with Mendeley

Sign up for free